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Abstract
The modelling of HIV trends in Tanzania uses surveillance data from antenatal clinics after
adjusting for the reduction in fertility of women living with HIV (WLWH). The rollout of HIV
care and treatment services has enabled many WLWH to start on antiretroviral treatment
(ART) earlier and are counselled on the options to prevent HIV transmission to their children.
The assumption that being HIV positive leads to lower fertility needs to be revisited. This
study aims to quantify the effect of ART program expansion on the fertility rate of WLWH in
Tanzania. We used Cox regression model to estimate fertility rate and associated factors
among WLWH of reproductive age (15–49 years) who enrolled in HIV care and treatment at
57 centers in Tabora from 2008 to 2014. A decomposition of Poisson regression was used
to explore the reasons for fertility rate differences observed among WLWH. A total of 6,397
WLWH aged 15–49 years were followed for a median time of 2.0 years. The total fertility
rate of 48.8/1,000 person years (95%CI: 44.6 to 52.9/1,000) was inversely proportional to
age and WHO clinical staging. WLWH on ART had higher fertility compared to those not
started on ART (aHR = 1.5, 95%CI: 1.2–1.9). Being married or cohabiting, having higher
CD4 cell count and not using contraceptives were associated with higher fertility rate. The
fertility rate after post-ART initiation was 54.95/1,000 and among pre-ART users was 40.52/
1,000, a difference of 14.43/1,000 in fertility rate between the groups. In the decomposition
analysis, proximate determinants of fertility rate among WLWH on ART accounted for a
93.8% smaller increase than expected. In an era of ART expansion in Tabora region, fertility
rates of WLWH increased. Higher fertility rates in women on ART may alter the estimation of
HIV prevalence and incidence.
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Introduction
The HIV epidemic continues to be a major public health problem around the world. In 2017,
approximately 37 million people were living with HIV (PLWH), of whom 25 million are in
sub-Saharan Africa [1]. The 2017 Tanzania Health Impact Survey (THIS) reported approxi-
mately 1.4 million PLWH in Tanzania, a prevalence of 5.0% among adults aged 15 to 64 years
(6.5% among females and 3.5% among males) [2].
Early in the pandemic, the relationship between HIV/AIDS and fertility was determined to
be largely biological and behavioral [3]. Some studies in sub-Saharan Africa reported that
prior to widespread availability of antiretroviral therapy (ART) there was an inverse relation-
ship between HIV/AIDS and fertility, particularly during the advanced stages of infection [4].
Fertility was lower among women living HIV (WLWH) than those living without HIV, with
the exception of those aged 15–19 years (3–5).
The Total Fertility Rate (TFR) in Tanzania was 5.7 births per woman in 2005, 5.4 in 2010
and 5.2 in 2015 [5]. Routinely collected data from antenatal clinics (ANC) are used to generate
country-specific trends in HIV prevalence to monitor the effectiveness of prevention and con-
trol measures, and are still using the assumptions of reduced fertility of WLWH in making
these estimates [6].
The rapid expansion of HIV Care and Treatment services has increased the number of peo-
ple taking ART with 21.1 million people on ART worldwide, and of these, 12.9 million are in
Eastern and Southern Africa [1]. In Tanzania, nearly all (91%) PLHIV aged 15 to 64 years who
knew their HIV status were receiving ART in 2016 [2]. The rollout has contributed to a greater
awareness of issues related to fertility and childbearing among WLWH [7]. Some studies have
reported an increasing overall fertility rate among WLWH and a smaller difference in fertility
rates between WLWH and those living without HIV [8]. Therefore, the increased access to
care and treatment services and ART uptake may affect the fertility of WLWH implying a need
to re-estimate the adjustment factors used in calculations of country-specific HIV estimates.
In Tanzania, to date, only one study has examined the impact of ART on fertility and it
focused on Kisesa in northwest Tanzania, and used population data from demographic surveil-
lance [8]. The study reported that the difference in fertility between WLWH and those living
without HIV are narrowing over time as ART becomes more widely available in communities
but did not explain how much of the change is attributable to other factors than ART [8].
Our study contributes to the growing literature on ART and fertility in Sub-Saharan Africa.
Routinely collected data from HIV Care and Treatment Centers (CTCs) in Tanzania was used
to assess the impact of ART on the fertility rate among WLWH from 2008 to 2014 after observ-
ing several changes in guidelines for management of HIV and AIDS [9–13].
Additionally, many studies conducted in Sub-Saharan Africa have highlighted factors asso-
ciated with fertility rates among people using ART and those who are not using ART medica-
tion. These factors include CD4 count, age, marital status, contraceptive use, body mass index
(BMI) and World Health Organization (WHO) clinical staging [8, 14, 15]. The contribution of
these factors on fertility rate change can be partitioned into two parts, the part that can be
explained due to changes in the characteristics of the participants (endowments, explained var-
iation) and the part that is due to changes in their coefficients in the statistical model (effect of
the factors, unexplained variation). Most studies of factors associated with ART on fertility
rate did not examine how these factors contribute (endowments and coefficients contribu-
tions) to the fertility rate changes among WLWH after initiation of ART. This study aimed at
assessing the impact of ART on fertility and other factors that were associated with fertility
rate among WLWH and estimates the contribution of each of these factors on fertility rate
[16].
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Methods
Clinical setting and data collection
The data was collected in Tabora region located in the central-western part of the country and
one of Tanzania’s 31 administrative regions. The region has seven councils, which are Tabora
Municipal, Igunga, Kaliua, Nzega, Sikonge, Urambo and Uyui district councils. The large part
of the area is semi-urban. Agriculture providing the main source of income and the majority
of people living in Tabora are Sukuma and Nyamwezi. According to the 2012 population and
housing census, there 2,291, 623 people living in Tabora with an average household size of 6.0
and sex ratio of 97 females to 100 males [17].
This study uses retrospective cohort analysis of de-identified routinely collected data from
the national HIV patient electronic database at 57 HIV clinics in Tabora, Tanzania. Patients
from these facilities were receiving HIV services on a regular basis and their demographic
characteristics, clinical examinations, treatment outcomes and pregnancy status were captured
in paper records and later entered into on-site electronic databases. The National AIDS Con-
trol Program (NACP) performed initial data cleaning. De-identified datasets were exported by
NACP and provided to the investigators for analysis.
Medical officers and medical assistants mainly provided HIV care and treatment for preg-
nant women, who then received ART from pharmacy assistants or nurses within the preven-
tion of mother-to-child transmission (PMTCT) section of ANC. HIV care and treatment
services, including CD4 cell count testing and ART, were provided at no charge to clients at all
government clinics.
At the first clinic visit (enrolment visit), demographic characteristics including age in years,
gender and marital status were captured. A clinical assessment including weight in kilograms,
height in centimeters, WHO clinical staging and CD4 cell count were performed and informa-
tion on family planning use was collected. Monthly follow-up visits were recommended for
patients followed before (pre- ART) and after ART initiation (post-ART initiation). At follow-
up visits, the clinical and ART status of each patient was reviewed and documented. Appropri-
ate clinical management (including ART initiation for those eligible) was provided as per
national guidelines. At this time, guidelines stated that CD4 cell count testing to assess ART
eligibility should be repeated every six months or more frequently if needed [13]. Health facili-
ties without a CD4 cell count machine out-sourced testing and the return of results depended
on the distance and availability of transport to and from the testing facility.
Data management and analysis
This analysis includes data of WLWH aged 15–49 years at 57 clinics in Tabora region enrolled
from January 2008 to December 2014. During this time, ART was initiated according to the
2008 WHO recommendations/2009 Tanzania guidelines, which recommended ART initiation
for all patients with WHO Stage 3 or 4 irrespective of CD4 cell count or patients with CD4 cell
count below 350cells/mL irrespective of the WHO stage [10]. Women with ART enrollment
information only and no follow-up information were excluded from the analysis. Women who
reported having received sterilization as a family planning method were excluded at the date of
reported sterilization. The dataset was closed on 31 June 2015, after each woman had at least
six months of follow-up visits.
Missing information on age, weight, length, CD4 cell count, and WHO clinical staging at
first visit were imputed from the closest measurements in the next visit of the same woman.
The main outcome of interest was new pregnancies and a woman may have multiple pregnan-
cies during the follow-up time. Women who became pregnant during follow-up were censored
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at their first visit in which they reported the pregnancy and uncensored twelve months after
delivery of the pregnancy. Fertility rates were calculated over the person-years from the date of
first clinic visit to the study until the date of censoring. Women were censored when they
became pregnant, died, or reached their 50th birthday. The follow up time was censored 90
days after the last clinic visit (last follow-up) or on 30 June 2015 (the end of the study).
Women newly diagnosed with HIV during their pregnancy were excluded from the analysis
until 12 months after delivery. For women who had undergone sterilization during the follow-
up period were censored from the date of sterilization. The follow-up period of women prior
to initiation of ART was designated as the ‘‘pre-ART” period, while follow-up period after ini-
tiation of ART was designated as the ‘‘post-ART initiation”. The fertility rates were calculated
per 1,000 person years. The fertility rate ratio from Mantel-Haenszel test with 95% confidence
intervals was used to compare the fertility rates across all levels of explanatory variables. The
Cox regression model was used to assess the factors that were independently associated with
fertility rate. The robust variance was used to control for health facility variability.
Multivariate decomposition models were used to assess association of various participant
characteristics on the changes in fertility rate among post-ART initiators. Generally, the model
partitions changes of fertility rate into two parts, namely, the part that is due to changes in
characteristics of the variables (endowments, explained variation) and the part that is due to
changes of the coefficients of these variables for post-ART initiators (effect of the factors them-
selves). All analyses were conducted in Stata 13.0 (StataCorp, College Station, TX).
Ethical considerations
Ethical approval was received from the Kilimanjaro Christian Medical University College
Research and Ethics Review Committee No. 886, 2015. A Data Transfer Agreement from
National AIDS Control Program (NACP) was obtained in order to use the patient’s level infor-
mation from the CTC. Personal identifications including names, phone numbers, and house-
hold identifiers were removed from the database by NACP.
Results
Baseline characteristics of participants
Information of 11,987 non-pregnant WLWH were extracted from the NACP database, with
10,181 (85%) aged 15 to 49 years at the time of enrolment. A total of 3,784 (37.2%) women
were excluded from the analysis as only one visit was recorded in the NACP database, leaving
6,397 women included for the analysis (Fig 1).
Comparison of those who were included in the study (6,397) and the participants excluded
from the final analysis (3,784) indicated that there were no significant differences with regard
to age, marital status and contraceptive use (data not shown). Majority of those excluded
(82%) were not on ART.
The maximum study follow-up time was 7.4 years, with a median follow-up time of 2.0
years.
A cohort 6,397 WLWH from 2008 to 2014 was followed for a total of 10,800 years (median
2.0 years). We observed 523 new pregnancies. The total fertility rate was 48.5/1,000, person
years. The age-specific fertility rates were higher among younger women (96.1/1,000 in ages
20–24 and 91.5/1,000 in ages 15–19 years), and decreased with increasing age. Women who
were married or cohabiting had higher fertility (56/1,000) compared to those who were single
(36.5/1,000) or divorced/widowed (37.2/1,000). Women who were not using any contracep-
tion method had higher fertility rate (57.0/1,000) than those reported using contraception
(6.6/1,000). Furthermore, we observed an upward trend in fertility over time from the year
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2008 to 2014. The fertility was 35.4/1,000 person years in 2008 and this fertility rate was almost
three times higher six years later (94.7/1,000 years in 2014). In 2010, the fertility rate dropped
from 45.7/1,000 person years in 2009 to 28.9/1,000 in 2010 (Table 1 and Fig 2).
Fertility rates pre- and post- ART initiation
In pre-ART, we observed 3,413 (53.4%) women and 2,984 (46.6%) post-ART initiation. The
total fertility in the post-ART group was 55.0/1000 compared to 40.5/1000 in pre-ART group
giving an overall fertility rate 1.3 times higher in women on ART compared to those who are
not on ART (RR = 1.3, 95% CI 1.1–1.6) (Table 2).
Women aged 15–24 years old had a higher fertility rate (for pre-ART: aged 15–19 years was
70.9/1,000 and 20–24 was 81.1/1,000 and for post-ART: aged 15–19 years was 115.2/1,000 and
20–25 was 109.8/1,000) compared to women of older ages for both pre-ART and post-ART
groups. Little difference was noted between the pre and post ART groups amongst older
women (over 39 years) for example women between 35–39 years had a pre-ART fertility rate
of 15.2/1000 compared to a post-ART fertility rate of 15.9/1000. The fertility rates in post-ART
and pre-ART also differed by marital status, whereby women who were in the post ART group
and married or cohabiting had a higher fertility rate (61.6/1000 compared to 49.4/1000 in pre-
ART group. We observed a small difference in fertility between pre-ART (28.3/1000, 95%CI
Fig 1. The flow chart of women enrolled at the clinic and those included in the final analysis.
https://doi.org/10.1371/journal.pone.0222173.g001
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19.3–41.6/1000) and post-ART in 2010 (29.7/1000, 95%CI (19.1–46.0/1000) [9] and bigger dif-
ference in 2014, 102/1000 (95%CI 84.3–123.4) in post-ART group compared to 65.4/1000
(95%CI 40.7–105.2) in pre-ART group (Table 2).
The effect of ART and other factors on fertility rate
We predicted the effect of ART on fertility by controlling for health facility variabilities, age,
reported marital status, and reported modern family planning use. The fertility rate of women
in the post-ART group was 50% higher than women in the pre-ART group (adjusted HR
(AHR) = 1.5, 95%CI: 1.2–1.9). The fertility rate decreased with increasing age, where women
aged 40–49 years had a 90% lower fertility rate than women aged between 15 to 19 years
Table 1. Baseline characteristics of women living with HIV included in the final analysis.
Factors Total women
(%)
Person years (in 1000) Pregnancies (%) Pregnancy rate/1000 person years 95% CI/1000 person years
All patients 6,397 (100) 10.8 523 48.5 44.6–52.9
Age (Years)
15–19 783 (12.2) 1.0 89 91.5 74.3–112.6
20–24 1,262 (19.7) 1.8 169 96.1 82.7–111.8
25–29 1,322 (20.7) 2.2 145 64.8 55.1–76.2
30–34 1,272 (19.9) 2.4 84 34.6 28.0–42.9
35–39 807 (12.6) 1.5 24 15.6 10.4–23.3
40–49 951 (14.9) 1.8 12 6.5 3.7–11.5
Marital status
Single 1,260 (19.7) 1.9 71 36.5 28.9–46.1
Divorced/Widowed 1,392 (21.8) 2.3 84 37.2 30.0–46.0
Married/Cohabiting 3,745 (58.5) 6.6 368 56.0 50.5–62.0
CD4 cell count
� 350 2,739 (42.8) 4.1 189 46.2 40.1–53.3
> 350 3,658 (57.2) 6.7 334 49.9 44.9–55.6
Contraceptive use
Using 1,821 (28.5) 1.8 12 6.6 3.8–11.6
Not using 4,576 (71.5) 9.0 511 57.0 52.3–62.2
BMI
Above 24Kg/m2 508 (8.0) 1.1 54 50.0 38.3–65.2
18-24Kg/m2 3,201 (50.0) 6.2 329 53.2 47.7–59.2
Below 18Kg/m2 2,688 (42.0) 3.5 140 39.9 33.8–47.1
WHO Clinical staging
WHO stage IV 888 (13.9) 1.8 62 34.3 26.8–44.1
WHO stage III 2,050 (32.1) 3.6 133 37.1 31.3–43.9
WHO stage II 1,882 (29.4) 2.9 132 45.8 38.6–54.3
WHO stage I 1,577 (24.7) 2.5 196 78.5 68.2–90.3
Year
2008 1,066 (16.7) 2.0 69 35.4 27.9–44.8
2009 758 (11.9) 1.4 63 45.7 35.7–58.5
2010 854 (13.4) 1.6 46 28.9 21.6–38.6
2011 909 (14.2) 1.7 69 39.9 31.5–50.5
2012 891 (13.9) 1.4 68 47.1 37.1–59.7
2013 924 (14.4) 1.4 85 61.6 49.8–76.2
2014 995 (15.6) 1.3 123 94.7 79.3–113.0
https://doi.org/10.1371/journal.pone.0222173.t001
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(AHR = 0.1, 95%CI: 0.03–0.1). The fertility rate of married or cohabiting women was 1.5 times
higher than women who reported to be single (AHR = 1.5, 95%CI: 1.2–2.0). The fertility rate
of women with a CD4 count of 350 cells or more was 20% higher than women with a CD4
count of less than 350 cells (AHR = 1.2, 95%CI: 1.0–1.3). The fertility rate of women with a
lower WHO clinical staging (stage one) were two-fold higher than those classified at WHO
stage four (AHR = 2.3, 95%CI: 1.7–3.1) and the fertility rate of the women enrolled in the
study in the year 2014 was twice as high as the fertility rate of those who were enrolled in the
year 2008. There was no statistical difference in the fertility rate of women who reported to
have a BMI below 24kg/m2 compared to those with a BMI above 24kg/m2 (Table 3).
Decomposition analysis for factors associated with fertility rate
The fertility rate among post-ART was 54.95 births per 1000 person years and among pre-
ART women was 40.52 births per 1000 person years, yielding an increased by 14.43 births per
1000 person years in women on ART, compared to those not on ART (Table 4). However,
there was an increase in the number of women using contraceptives among women on ART
(34.2%), compared to those not on ART (23.4%). If this had not happened, there would have
been a further 58.7% increase in the fertility of those on ART. The factors in the decomposition
analysis showed age (24.5%) WHO staging (17.2%) and contraception use (58.7%) was associ-
ated with lower fertility among those on ART while the BMI (11.0%) was correlated with
higher fertility among those on ART, compared to those not on ART. Overall if these factors
had been similar among the women on ART to those not on ART the increase would have
been 93.8% higher, with an additional increase of 13.5 births per 1000 person years. In this
case, the overall fertility rate would have been 68.45 per 1000 person years (Table 5).
Discussion
Effect of ART on fertility rate
The findings from this study showed that the fertility rate among WLWH who were on ART
was 50% higher than WLWH who had not yet started on ART. The higher fertility rate
Fig 2. Trend in fertility rates in women living with HIV from 2008 to 2014.
https://doi.org/10.1371/journal.pone.0222173.g002
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observed amongst women taking ART is consistent with other studies in Tanzania and across
the region [8, 14, 15]. The use of ART has been reported in other studies to improve immuno-
logical functioning and increase female fecundity and fertility desire [18–20]. Therefore, avail-
ability of free ART in Tanzania in 2004 with ongoing training for healthcare providers may
have elevated the confidence of WLWH and motivated them to resume sexual activity and
consequently increased the chances of becoming pregnant [21].
Factors associated with fertility rate change
The fertility rate of women in this study was inversely related with age and this findings aligns
with previous studies [22–24]. These findings mirror the general population where women are
Table 2. Total fertility of participants by pre-ART and post-ART status.
Factor Total women Pre-ART Post-ART
Person-years Pregnancy fertility Rate/1000
Rate(95%CI)
Person-years Pregnancy fertility Rate/1000
Rate(95%CI)
All women 6,397 4.8 194 40.5(35.2–46.7) 6.0 329 55.0(49.3–61.2)
Age (Years)
15–19 783 0.5 37 70.9(51.4–97.9) 0.5 52 115.2(87.8–151.2)
20–24 1,262 0.8 68 81.1(64.0–102.9) 0.9 101 109.8(90.3–133.4)
25–29 1,322 0.9 47 49.7(37.4–66.2) 1.3 98 75.8(62.2–92.4)
30–34 1,272 1.0 29 28.2(19.6–40.5) 1.4 55 39.4(30.2–51.3)
35–39 807 0.7 10 15.2(8.2–28.4) 0.9 14 15.9(9.4–26.8)
40–49 951 0.8 3 3.8(1.2–11.6) 1.1 9 8.6(4.5–16.5)
Marital status
Single 1,260 0.8 21 25.8(16.8–39.6) 1.1 50 44.2(33.5–58.3)
Divorced/Widowed 1,392 1.0 24 25.0(16.7–37.3) 1.3 60 46.2(35.9–59.5)
Married/Cohabiting 3,745 3.0 149 49.4(42.1–58.1) 3.6 219 61.6(53.9–70.3)
CD4 cell count
� 350 2,739 1.8 57 32.0(24.7–41.5) 2.3 132 57.2(48.2–67.8)
> 350 3,658 3.0 137 45.5(38.5–53.8) 3.7 197 53.6(46.6–61.6)
Contraceptive
Using 1,821 0.7 1 1.5(0.2–10.6) 1.1 11 9.6(5.3–17.4)
Not using 4,576 4.1 193 46.9(40.7–54.0) 4.8 318 65.6(58.8–73.3)
BMI
Above 24Kg/m2 508 0.4 15 35.7(21.5–59.2) 0.7 39 59.1(43.2–80.9)
18-24Kg/m2 3,201 2.6 114 43.6(36.3–52.4) 3.6 215 60.1(52.6–68.7)
Below 18Kg/m2 2,688 1.8 65 37.0(29.0–47.2) 1.8 75 42.8(34.1–53.7)
WHO Staging
WHO stage IV 888 0.5 16 29.4(18.0–48.1) 1.3 46 36.5(27.3–48.7)
WHO stage III 2,050 1.3 25 18.7(12.6–27.7) 2.3 108 48.0(39.7–57.9)
WHO stage II 1,882 1.5 63 42.6(33.3–54.6) 1.4 69 49.1(38.8–62.1)
WHO stage I 1,577 1.4 90 62.9(51.1–77.4) 1.1 106 99.3(82.1–120.2)
Year
2008 1,066 1.3 41 32.0(23.6–43.5) 0.7 28 41.7(28.8–60.4)
2009 758 0.8 32 40.9(28.9–57.8) 0.6 31 52.0(36.6–74.0)
2010 854 0.7 20 29.7(19.1–46.0) 0.9 26 28.3(19.3–41.6)
2011 909 0.8 26 33.4(22.8–49.1) 1.0 43 45.1(33.5–60.9)
2012 891 0.6 28 47.4(32.7–68.6) 0.9 40 46.9(34.4–64.0)
2013 891 0.4 30 71.1(49.7–101.7) 1.0 55 57.4(44.1–74.7)
2014 995 0.3 17 65.4(40.7–105.2) 1.0 106 102.0(84.3–123.4)
https://doi.org/10.1371/journal.pone.0222173.t002
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Table 3. Factors associated with fertility rate.
Factors Crude HR
(95% C.I.)
p-value (Likelihood ratio test) adjusted HR
(95% C.I.)
p-value (Likelihood ratio test)
Age (Years) <0.0001
15–19 1.0 1.0
20–24 1.0 (0.8–1.3) 0.753 1.0 (0.8–1.3)
25–29 0.7 (0.5–0.9) 0.003 0.7 (0.5–0.9)
30–34 0.3 (0.3–0.5) <0.001 0.3 (0.2–0.5)
35–39 0.2 (0.1–0.2) <0.001 0.2 (0.1–0.3)
40–49 0.1 (0.03–0.1) <0.001 0.1 (0.03–0.1)
Marital status <0.0024
Single 1.0 1.0
Divorced/Widowed 1.0 (0.7–1.4) 0.890 1.3 (0.9–1.9)
Married/Cohabiting 1.5 (1.2–2.0) 0.001 1.5 (1.2–2.0)
ART status 0.0001
Pre-ART 1.0 1.0
On-ART 1.3 (1.1–1.6) 0.002 1.5 (1.2–1.9)
CD4 cell count 0.0051
� 350 1.0 1.0
> 350 1.0 (0.9–1.2) 0.681 1.2 (1.0–1.3)
Contraceptive use <0.0001
Using modern family planning method 1.0 1.0
Not using modern family planning method 8.7 (4.8–15.8) <0.001 10 (5.7–21.0)
BMI 0.1176
Above 24Kg/m2 1.0 1.0
18-24Kg/m2 1.1 (0.8–1.4) 0.586 1.1 (0.8–1.4)
Below 18Kg/m2 0.8 (0.6–1.1) 0.246 0.9 (0.7–1.1)
WHO Staging <0.0001
WHO stage IV 1.0 1.0
WHO stage III 1.1 (0.8–1.6) <0.001 1.2 (0.9–1.5)
WHO stage II 1.5 (1.1–2.0) <0.001 1.5 (1.1–2.0)
WHO stage I 2.6 (1.9–3.4) <0.001 2.3 (1.7–3.1)
Year of Enrollment <0.0001
2008 1
2009 1.3 (0.9–1.9) 0.100 1.2 (0.7–2.0)
2010 0.9 (0.6–1.2) 0.403 0.7 (0.5–0.9)
2011 1.2 (0.8–1.6) 0.340 0.9 (0.6–1.3)
2012 1.4 (1.0–2.0) 0.037 1.2 (0.7–2.2)
2013 1.9 (1.4–2.6) <0.001 1.5 (0.9–2.7)
2014 2.7 (2.0–3.6) <0.001 1.9 (1.1–3.2)
https://doi.org/10.1371/journal.pone.0222173.t003
Table 4. Fertility gaps of women on-ART and those not on-ART.
Exposure of interest Number of Pregnancies Person years/1000 Fertility rate/ 1000 years 95%C1
Lower
Upper
Post-ART 329 5.99 54.95 49.32 61.22
Pre-ART 194 4.79 40.52 35.20 46.64
Difference 130 1.20 14.43 14.12 14.58
https://doi.org/10.1371/journal.pone.0222173.t004
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mostly fertile between the ages of 20 and 24 years [24]. The younger women in this study were
more likely to be pregnant compared to older women regardless of their ART status.
Modern family planning was inversely associated with fertility rate. This study reported
lower use of modern family compared to general population (28% compared to 32%) [5]. In
Tanzania, the use of any method of family planning among married women aged 15–49 is 32%
[5]. WLWH have critical family planning needs [25]; studies in sub-Saharan Africa suggest
that more than half of pregnancies in WLWH are unintended [26, 27]. Family planning needs
of WLWH must be met to not only reduce mother-to-child HIV transmission but also as an
essential component of HIV Prevention program. WLWH aspire to have children, and guide-
lines on safer conception are available in developed countries and in South Africa [28] to sup-
port their need to conceive while reducing horizontal or vertical HIV transmission. This
becomes even more pertinent in the era of ART and in the context of the increasing fertility
rates of HIV infected women. It is a call for other countries including Tanzania to consider
including safer conception strategies into policy and reproductive child health guideline.
The higher fertility rate reported in 2014 was partly contributed by improved data capture
system observed in the year ending 2013 and beginning of 2014. In one-third of all facilities
used in this study, shifted from using paper-based, and moved to electronic-based data capture
Table 5. Decomposition analysis.
Characteristics Total Fertility Rates difference Difference in Endowments Difference in coefficients
Value % Value % Value %
Overall 14.4 100.0 -13.5 -93.8 28.0 193.8
Characteristics
Age (Total) -3.4 -23.8 -3.5 -24.5 0.1 0.7
40–49 0.8 5.8 -0.8 -5.9 1.7 11.7
35–39 -2.0 -14.1 -0.8 -5.2 -1.3 -8.8
30–34 -1.0 -6.7 0.0 -0.3 -0.9 -6.4
25–29 0.3 2.0 0.1 0.8 0.2 1.2
20–24 -0.6 -3.9 -0.6 -4.2 0.0 0.3
15–19 -1.0 -6.9 -1.4 -9.7 0.4 2.7
Marital status (Total) -1.6 -11.1 -0.2 -1.2 -1.4 -9.9
Single -0.6 -3.8 -0.1 -0.6 -0.5 -3.3
Divorced/Widowed 1.4 9.6 0.0 0.1 1.4 9.5
Married/Cohabiting -2.4 -16.8 -0.1 -0.7 -2.3 -16.1
CD4 cell count (Total) -0.8 -5.8 -0.5 -3.2 -0.4 -2.6
CD4 350 cells or less 0.4 2.9 -0.2 -1.6 0.6 4.4
CD4 Above 350 cells -1.3 -8.7 -0.2 -1.6 -1.0 -7.1
Contraceptive use (Total) -21.6 -149.6 -8.5 -58.7 -13.1 -90.9
Not using contraceptive 1.5 -160.3 -4.2 -29.4 5.8 -131.0
Using contraceptive -23.1 10.7 -4.2 -29.4 -18.9 40.1
BMI (Total) -0.4 -2.7 1.6 11.0 -2.0 -13.8
Below 18Kg/cm2 -1.7 -12.1 1.1 7.4 -2.8 -19.5
18-24Kg/cm2 0.9 6.4 0.4 2.9 0.5 3.5
Above 24Kg/cm2 0.4 3.0 0.1 0.8 0.3 2.2
WHO Clinical staging (Total) -1.5 -10.5 -2.5 -17.2 1.0 6.8
WHO stage I -1.4 -9.9 -1.6 -11.0 0.2 1.2
WHO stage II -2.6 -17.9 0.2 1.5 -2.8 -19.4
WHO stage III 4.2 28.9 -0.1 -1.0 4.3 29.9
WHO stage IV -1.7 -11.6 -1.0 -6.7 -0.7 -4.9
https://doi.org/10.1371/journal.pone.0222173.t005
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(CTC2 database). The increase of number of facilities using CTC2 may have contributed to
higher new pregnancies reported into the CTC2 database. Given the same trend, if all facilities
were using CTC2 database higher fertility rate may have been reported.
Decomposition of the changes in uptake of HIV testing
This shows that, fertility increased by 14.43 births per 1000 person years in women on ART,
compared to those not on ART. Other studies have reported higher fertility among WLWH
using ART compared to those not on ART [8, 14, 15]. The use of contraception in this study
increased after WLWH started using ART (from 23.4% to 34.2%). The overall fertility rate
would have been at 66.5 per person years in women using ART, if the participants’ characteris-
tics’ had remained the same as the women who were not using ART. In Tanzania, the national
guideline for management of HIV and AIDS allows every person living with HIV to start ART
immediately after HIV diagnosis. Therefore, as ART becomes more widely available for long
time, the fertility rate among WLWH will increase and the gap between HIV positive women
and general population will be reduced. A previous study has also reported a decrease over
time in fertility gap between WLWH and those living without HIV [8]. Therefore, those mod-
els that assume lower fertility among WLWH when calculating predictions for national HIV
prevalence need to consider the effect of ART among WLWH especially when more than 90%
of WLWH who know their HIV status are currently on ART [2].
This study is based on recorded data in patients’ database the interpretation of the findings
should consider the following limitations. First, the use of self-report for pregnancy that likely
led to an underestimate of the true fertility rate because some of pregnancies resulting in spon-
taneous abortion prior to detection and some of the elective abortions may have been under
reported however, this ascertainment challenge is not associated with use of ART.
Conclusion
The fertility rate of WLWH on ART is higher than those pre-ART; although still lower than
the fertility among women living without HIV. As ART continues to be widely available, and
accessible we would expect its effect to impact the fertility trend in the general population.
Therefore, there is a need to revisit the assumption that being an HIV positive women leads to
a lower fertility rate when national HIV prevalence estimates are calculated. Additionally, the
results presented in this research support the call to strengthen the integration of reproductive
health counseling such as family planning in HIV services in order to prevent unwanted preg-
nancies and, for planned pregnancies, prevent HIV transmission to children and uninfected
partners.
Differences in fertility rate between WLWH receiving ART and those not on ART exist.
With more WLWH receiving ART at the point of HIV positive diagnosis, the gap in fertility
between WLWH and those living without HIV will narrow. Therefore, the modelling of HIV
trends in Tanzania using surveillance data from ANC after adjusting for the reduction in fertil-
ity of WLWH needs to be adjusted to allow for the impact of treatment.
Acknowledgments
We thank the Ministry of Health for their permission to use the data. We acknowledge the
hard work of clinic staff in managing the women in CTC, and collecting the data. We acknowl-
edge the work of NACP in managing and preparing the data for use in this paper. This work
was supported through the DELTAS Africa Initiative grant # DEL-15-011 to THRiVE-2. The
DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sci-
ences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported
Fertility rate among women living with HIV receiving ART in Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0222173 September 6, 2019 11 / 14
by the New Partnership for Africa’s Development Planning and Coordinating Agency
(NEPAD Agency) with funding from the Wellcome Trust grant # 107742/Z/15/Z and the UK
government. The views expressed in this publication are those of the author(s) and not neces-
sarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. Gaspar Mbita
was partly supported for his MSc studies by THRiVE, and partly by his employer, Elizabeth
Glaser Pediatric AIDS Foundation who also provided his study leave. Jim Todd and Jenny
Renju receive salary support from THRiVE.
Author Contributions
Conceptualization: Gaspar Mbita, Jenny Renju, Jim Todd.
Data curation: Gaspar Mbita, Gissenge Lija, Jim Todd.
Formal analysis: Gaspar Mbita, Jenny Renju, Gissenge Lija, Jim Todd.
Funding acquisition: Gaspar Mbita, Jenny Renju, Jim Todd.
Investigation: Gaspar Mbita.
Methodology: Gaspar Mbita, Jenny Renju, Jim Todd.
Project administration: Gaspar Mbita, Jim Todd.
Resources: Jenny Renju, Jim Todd.
Software: Gaspar Mbita, Jim Todd.
Supervision: Gaspar Mbita, Jenny Renju, Gissenge Lija, Jim Todd.
Validation: Gaspar Mbita, Gissenge Lija, Jim Todd.
Visualization: Gaspar Mbita.
Writing – original draft: Gaspar Mbita.
Writing – review & editing: Gaspar Mbita, Jenny Renju, Gissenge Lija, Donaldson F. Con-
serve, Jim Todd.
References
1. UNAIDS. UNAIDS DATA 2018. Available from: http://www.unaids.org/sites/default/files/media_asset/
unaids-data-2018_en.pdf.
2. PEPFAR. Tanzania HIV Impact Survey (THIS) 2016–2017 2017. Available from: https://phia.icap.
columbia.edu/wp-content/uploads/2017/11/Tanzania_SummarySheet_A4.English.v19.pdf.
3. Gregson S, Terceira N, Kakowa M, Mason PR, Anderson RM, Chandiwana SK, et al. Study of bias in
antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan
Africa. AIDS. 2002; 16(4):643–52. https://doi.org/10.1097/00002030-200203080-00017 PMID:
11873009
4. Yeatman S. HIV infection and fertility preferences in rural Malawi. Stud Fam Plann. 2009; 40(4):261–
76. https://doi.org/10.1111/j.1728-4465.2009.00210.x PMID: 21151844
5. Tanzania Ministry of Health CD, Gender, Elderly and Children. Tanzania Demographic and Health Sur-
vey and Malaria Indicator Survey 2016. Available from: https://dhsprogram.com/pubs/pdf/FR321/
FR321.pdf.
6. UNAIDS. Guidelines for Conducting HIV Sentinel Serosurveys among Pregnant Women and Other
Groups 2003 updated 2003. Available from: http://data.unaids.org/publications/irc-pub06/jc954-anc-
serosurveys_guidelines_en.pdf.
7. Gruskin S, Ferguson L, O’Malley J. Ensuring Sexual and Reproductive Health for People Living with
HIV: An Overview of Key Human Rights, Policy and Health Systems Issues. Reproductive Health Mat-
ters. 2007; 15(sup29):4–26.
Fertility rate among women living with HIV receiving ART in Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0222173 September 6, 2019 12 / 14
8. Marston M, Nakiyingi-Miiro J, Hosegood V, Lutalo T, Mtenga B, Zaba B, et al. Measuring the Impact of
Antiretroviral Therapy Roll-Out on Population Level Fertility in Three African Countries. PLoS One.
2016; 11(3):e0151877. https://doi.org/10.1371/journal.pone.0151877 PMID: 27015522
9. Tanzania Ministry of Health CD, Gender, Elderly and Children. National guidline for the management of
HIV and AIDS, 2nd Edition April 2005. 2005. Available from: https://www.google.com/search?ei=-
UOdXIX2A5TAgwe307aYDg&q=Tanzania+guidelines+for+management+of+HIV+and+AIDS+First
+edition+in+April%2C+2005%2C+&oq=Tanzania+guidelines+for+management+of+HIV+and+AIDS
+First+edition+in+April%2C+2005%2C+&gs_l=psy-ab.3..35i39.293990.293990..294976...0.0..0.860.
860.6-1......0....2j1..gws-wiz.......0i71.gwKbuufiAcA.
10. Tanzania Ministry of Health CD, Gender, Elderly and Children. National guidline for the management of
HIV and AIDS, 4th Edition 2012. Available from: https://aidsfree.usaid.gov/sites/default/files/hts_
policy_tanzania.pdf.
11. Tanzania Ministry of Health CD, Gender, Elderly and Children. National guidline for the management of
HIV and AIDS, 5th Edition May 2015 2015. Available from: https://aidsfree.usaid.gov/sites/default/files/
04_11_2016.tanzania_national_guideline_for_management_hiv_and_aids_may_2015._tagged.pdf.
12. Tanzania Ministry of Health CD, Gender, Elderly and Children. National guidline for the management of
HIV and AIDS, 6th Edition December 2017 2017. Available from: https://www.google.com/search?ei=
XEOdXJDcKoiejLsP24eGwAc&q=Tanzania+guidelines+for+management+of+HIV+and+AIDS+sixth
+edition+in+December%2C+2017&oq=Tanzania+guidelines+for+management+of+HIV+and+AIDS
+sixth+edition+in+December%2C+2017&gs_l=psy-ab.3...126434.126434..127699...0.0..0.281.281.2-
1......0....2j1..gws-wiz.......0i71.0_12B8WUyzQ.
13. Tanzania Ministry of Health CD, Gender, Elderly and Children. National guidline for the management of
HIV and AIDS, third Edition February 2009 2019. Available from: https://www.who.int/hiv/pub/
guidelines/tanzania_art.pdf.
14. Makumbi FE, Nakigozi G, Reynolds SJ, Ndyanabo A, Lutalo T, Serwada D, et al. Associations between
HIV Antiretroviral Therapy and the Prevalence and Incidence of Pregnancy in Rakai, Uganda. AIDS
Res Treat. 2011; 2011:519492. https://doi.org/10.1155/2011/519492 PMID: 21490780
15. Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on inci-
dence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med.
2010; 7(2):e1000229. https://doi.org/10.1371/journal.pmed.1000229 PMID: 20161723
16. Sinning MaH, Markus and Bauer Thomas. The Blinder–Oaxaca decomposition for nonlinear regression
models. Stata Journal. 2008; 8(4):480–92.
17. Statistics TNBo. 2012 Population and Housing Census 2013 [Available from: http://www.tzdpg.or.tz/
fileadmin/documents/dpg_internal/dpg_working_groups_clusters/cluster_2/water/WSDP/Background_
information/2012_Census_General_Report.pdf.
18. Kipp W, Heys J, Jhangri GS, Alibhai A, Rubaale T. Impact of antiretroviral therapy on fertility desires
among HIV-infected persons in rural Uganda. Reprod Health. 2011; 8:27. https://doi.org/10.1186/1742-
4755-8-27 PMID: 21975089
19. Maier M, Andia I, Emenyonu N, Guzman D, Kaida A, Pepper L, et al. Antiretroviral therapy is associated
with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treat-
ment program in rural Uganda. AIDS Behav. 2009; 13 Suppl 1:28–37.
20. Myer L, Rebe K, Morroni C. Missed opportunities to address reproductive health care needs among
HIV-infected women in antiretroviral therapy programmes. Trop Med Int Health. 2007; 12(12):1484–9.
https://doi.org/10.1111/j.1365-3156.2007.01955.x PMID: 18076556
21. Pearson CR, Cassels S, Kurth AE, Montoya P, Micek MA, Gloyd SS. Change in sexual activity 12
months after ART initiation among HIV-positive Mozambicans. AIDS Behav. 2011; 15(4):778–87.
https://doi.org/10.1007/s10461-010-9852-3 PMID: 21082338
22. Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, Lutalo T, et al. Effect of HIV infection on preg-
nancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data
from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). The
Lancet. 2013; 381(9879):1763–71.
23. Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello AR, et al. Incidence and predic-
tors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara,
Uganda. PLoS One. 2013; 8(5):e63411. https://doi.org/10.1371/journal.pone.0063411 PMID:
23704906
24. Kabami Jane TE, Biraro Sam, Bajunirwe Francis. Increasing incidence of pregnancy among women
receiving HIV care and treatment at a large urban facility in western Uganda. Reproductive Health.
2014; 11.
Fertility rate among women living with HIV receiving ART in Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0222173 September 6, 2019 13 / 14
25. Baumgartner JN, Green M, Weaver MA, Mpangile G, Kohi TW, Mujaya SN, et al. Integrating family
planning services into HIV care and treatment clinics in Tanzania: evaluation of a facilitated referral
model. Health Policy Plan. 2014; 29(5):570–9. https://doi.org/10.1093/heapol/czt043 PMID: 23894070
26. Habte D, Namasasu J. Family planning use among women living with HIV: knowing HIV positive status
helps—results from a national survey. Reprod Health. 2015; 12:41. https://doi.org/10.1186/s12978-
015-0035-6 PMID: 25958383
27. Wanyenze RK, Tumwesigye NM, Kindyomunda R, Beyeza-Kashesya J, Atuyambe L, Kansiime A, et al.
Uptake of family planning methods and unplanned pregnancies among HIV-infected individuals: a
cross-sectional survey among clients at HIV clinics in Uganda. J Int AIDS Soc. 2011; 14:35. https://doi.
org/10.1186/1758-2652-14-35 PMID: 21718524
28. Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, Black V. High incidence of unplanned pregnancy
after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One.
2012; 7(4):e36039. https://doi.org/10.1371/journal.pone.0036039 PMID: 22558319
Fertility rate among women living with HIV receiving ART in Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0222173 September 6, 2019 14 / 14
